Trade Summary

5 months ago, Nijhawan Pardeep, serving as CEO, 10% owner at Edesa Biotech, Inc. (EDSA), purchased 50,571 shares at $1.96 per share, for a total transaction value of $99,176.00. Following this transaction, Nijhawan Pardeep now holds 1,115,241 shares of EDSA.

This purchase represents a 5.00% increase in Nijhawan Pardeep's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, February 26, 2026 and publicly disclosed via SEC Form 4 filing on Monday, March 2, 2026 at 5:05 PM ET, 4 days after the trade was made.

Edesa Biotech, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.